Digest Network How does it work
Network
/
Society
EG
Not verified

EG 427

What we write about

Advertising / Marketing / Media / CommunicatiBiotechnologyFinanceMedical Health Wellness

9 Press releases

View all press releases
05/10/2025
Advertising / Marketing / Media / Communicati
Medical Health Wellness
EG 427 Receives U.S. FDA Fast Track Designation for EG110A DNA Medicine in Neurogenic Bladder Patients
Source
EG 427
Issuer
GLOBENEWSWIRE
1.00
0
01/10/2025
Advertising / Marketing / Media / Communicati
Medical Health Wellness
EG 427 annonce des résultats cliniques initiaux majeurs avec EG110A, son médicament à ADN chez des patients atteints de vessie neurogène
Source
EG 427
Issuer
GLOBENEWSWIRE
1.00
0
01/10/2025
Advertising / Marketing / Media / Communicati
Medical Health Wellness
EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients
Source
EG 427
Issuer
GLOBENEWSWIRE
1.00
0
Press Release cover image
12/05/2025
Advertising / Marketing / Media / Communicati
Medical Health Wellness
EG 427 présente à l’ASGCT des avancées majeures réalisées avec sa plateforme HERMES en neurologie, démontrant la polyvalence de ses vecteurs herpétiques non-réplicatifs
Source
EG 427
Issuer
GLOBENEWSWIRE
1.00
0
Press Release cover image
12/05/2025
Advertising / Marketing / Media / Communicati
Medical Health Wellness
EG 427 highlights at ASGCT major advances made with its HERMES platform in neurology using versatile non-replicative herpes vectors
Source
EG 427
Issuer
GLOBENEWSWIRE
1.00
0
Press Release cover image
26/02/2025
Biotechnology
Avancée majeure pour EG 427 avec le premier patient traité par EG110A, la première thérapie génique à base d’un vecteur herpétique non réplicatif pour le traitement de la vessie neurogène
Source
EG 427
Issuer
GLOBENEWSWIRE
1.00
0
Press Release cover image
26/02/2025
Biotechnology
Significant milestone reached for EG 427 with first patient treated with EG110A, first non-replicative herpes vector based genetic medicine for the treatment of neurogenic bladder
Source
EG 427
Issuer
GLOBENEWSWIRE
1.00
0
Press Release cover image
19/02/2025
Biotechnology
Finance
EG 427 lève 27 millions d’euros lors d’un tour de financement de série B mené conjointement par Andera Partners et Bpifrance pour financer son étude clinique en cours et le développement de sa plateforme
Source
EG 427
Issuer
GLOBENEWSWIRE
1.00
0
Press Release cover image
19/02/2025
Biotechnology
Finance
EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform development
Source
EG 427
Issuer
GLOBENEWSWIRE
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0